James C. Foster
Known title: DirectorCIK: 0001141722
James C. Foster's purchase track record
James C. Foster has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/20/2025 | CRL | $1.00M | -16.4% | -4.8% | +4.1% |
| 11/14/2023 | CRL | $1.00M | +23.5% | +30.5% | +16.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CRL | ▲ Buy | Option Exercise | 21,132 | $4.1M | 8/25/2026 | View on chart |
| CRL | ▲ Buy | Option Exercise | 12,429 | $2.6M | 8/25/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 33,561 | $10.1M | 8/25/2026 | View on chart |
| CRL | ▲ Buy | Option Exercise | 28,733 | $5.2M | 8/10/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 28,733 | $7.9M | 8/10/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 75,000 | $16.9M | 6/29/2026 | View on chart |
| CRL | ▼ Sell | Gift | 153,361 | $0 | 6/5/2026 | View on chart |
| CRL | ▼ Sell | Gift | 153,361 | $0 | 6/5/2026 | View on chart |
| CRL | ▼ Sell | Gift | 20,000 | $0 | 6/5/2026 | View on chart |
| CRL | ▼ Sell | Gift | 20,000 | $0 | 6/5/2026 | View on chart |
| CRL | ▼ Sell | Gift | 10,000 | $0 | 6/5/2026 | View on chart |
| CRL | ▼ Sell | Gift | 10,000 | $0 | 6/5/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 1,596 | $288K | 5/30/2026 | View on chart |
| CRL | ▲ Buy | Grant | 1,438 | $255K | 5/8/2026 | View on chart |
| CRL | ▲ Buy | Grant | 422 | $75K | 5/8/2026 | View on chart |
| CRL | ▲ Buy | Grant | 16,796 | $3.0M | 3/2/2026 | View on chart |
| CRL | ▲ Buy | Grant | 39,031 | $0 | 1/30/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 14,664 | $3.1M | 1/30/2026 | View on chart |
| CRL | ▲ Buy | Grant | 17,253 | $2.3M | 5/30/2025 | View on chart |
| CRL | ▲ Buy | Open Market | 6,075 | $1.0M | 2/20/2025 | View on chart |
| CRL | ▲ Buy | Grant | 19,608 | $0 | 1/31/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 6,827 | $1.1M | 1/31/2025 | View on chart |
| CRL | ▼ Sell | Gift | 4,500 | $0 | 11/8/2024 | View on chart |
| CRL | ▼ Sell | Gift | 2,500 | $0 | 8/12/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 25,000 | $6.3M | 8/1/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 1,274 | $273K | 5/29/2024 | View on chart |
| CRL | ▼ Sell | Gift | 4,000 | $0 | 2/16/2024 | View on chart |
| CRL | ▲ Buy | Grant | 24,253 | $0 | 1/29/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 10,757 | $2.4M | 1/29/2024 | View on chart |
| CRL | ▲ Buy | Option Exercise | 17,436 | $2.5M | 1/29/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 12,710 | $2.9M | 1/29/2024 | View on chart |
| CRL | ▲ Buy | Open Market | 5,620 | $1.0M | 11/14/2023 | View on chart |
| CRL | ▼ Sell | Gift | 2,500 | $0 | 8/10/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 1,274 | $247K | 5/29/2023 | View on chart |
| CRL | ▼ Sell | Gift | 3,811 | $0 | 5/15/2023 | View on chart |
| CRL | ▼ Sell | Gift | 3,812 | $0 | 5/15/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 1,814 | $442K | 2/22/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 19,892 | $5.0M | 2/15/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 108 | $27K | 2/15/2023 | View on chart |
| CRL | ▲ Buy | Grant | 49,725 | $0 | 1/27/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 21,453 | $0 | 1/27/2023 | View on chart |
| CRL | ▼ Sell | Gift | 2,000 | $0 | 6/6/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 1,311 | $320K | 5/29/2022 | View on chart |
| CRL | ▲ Buy | Option Exercise | 20,296 | $2.2M | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 1,503 | $427K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 3,415 | $973K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 2,027 | $580K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 3,171 | $910K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 4,245 | $1.2M | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 805 | $233K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 1,078 | $313K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 1,259 | $366K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 981 | $286K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 746 | $218K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 325 | $95K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 389 | $115K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 352 | $104K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 1,770 | $513K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 1,610 | $473K | 2/22/2022 | View on chart |
| CRL | ▲ Buy | Option Exercise | 17,436 | $2.5M | 2/22/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 796 | $228K | 2/22/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 2,394 | $687K | 2/22/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 5,243 | $1.5M | 2/22/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 4,472 | $1.3M | 2/22/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 2,600 | $754K | 2/22/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 1,481 | $431K | 2/22/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 100 | $29K | 2/22/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 350 | $102K | 2/22/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 465 | $154K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 2,812 | $884K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 1,816 | $572K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 2,157 | $682K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 1,243 | $394K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 325 | $103K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 420 | $134K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 100 | $32K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 174 | $56K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 179 | $59K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 98 | $32K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 158 | $52K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 914 | $303K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 51 | $17K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 236 | $79K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 15 | $5K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 325 | $100K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 1,064 | $329K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 2,456 | $762K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 1,643 | $511K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 1,835 | $573K | 2/15/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 1,514 | $474K | 2/15/2022 | View on chart |
| CRL | ▲ Buy | Grant | 65,011 | $0 | 1/28/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 25,108 | $7.8M | 1/28/2022 | View on chart |
| CRL | ▼ Sell | Gift | 14,813 | $0 | 10/26/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
CRL Analyst Targets Rise After UBS Reinstates Coverage
Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.
CRL Analyst Targets Rise After UBS Reinstates Coverage. Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.